Most patients tolerate gradual dose increases without significant discontinuation problems
Special considerations for oral and alternative GLP-1 formulations Not all GLP-1 medications are injectable
There's a lot of people who are under the impression that if you are not diabetic and you're using these Medications that you you're selfishly taking a drug away from a diabetic and I would love to hear your take on that McCall McPhereson: Yeah, you know, I think the majority of people who are on these medications for weight [00:36:00] loss, either from, you know, a BMI too high, prediabetes, you know, obesity or overweight, but with a complication of that, you know, of being overweight
An exploratory study with sitagliptin and the GLP-1 receptor agonist liraglutide did not show additive effects, and whether there may be additional effects using shorter acting GLP-1 receptor agonists and DPP-4 inhibitors has not been studied yet (7072, 86)
Protein matters too
Research shows a longer breastfeeding duration is associated with reduced maternal rates of type 2 diabetes and less postpartum weight retention
